JANUS KINASE INHIBITORS USE IN PATIENTS WITH DUPILUMAB FACIAL REDNESS

被引：0
|
作者：
Choi, Hoon [1 ]
Kwak, Jun-Ho [1 ]
Jeong, Byung-Hoon [1 ]
Shim, Dong-Hyun [1 ]
Kim, Yong-Il [1 ]
Kim, Min-Sung [1 ]
Shin, Bong-Seok [1 ]
Na, Chan-Ho [1 ]
机构：
[1] Chosun Univ, Dept Dermatol, Coll Med, Gwangju, South Korea
来源：
ACTA DERMATO-VENEREOLOGICA | 2022年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P4.21
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [1] POSSIBLE EFFECTS OF ORAL JANUS KINASE INHIBITORS FOR DUPILUMAB FACIAL REDNESS
    Nakanishi, Mari
    Tamagawa-Mineoka, Risa
    Masuda, Koji
    Katoh, Norito
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 35 - 35
  • [2] Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians
    Muzumdar, Sonal
    Skudalski, Lauren
    Sharp, Kelley
    Waldman, Reid A.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (01) : 61 - 67
  • [3] Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians
    Sonal Muzumdar
    Lauren Skudalski
    Kelley Sharp
    Reid A. Waldman
    American Journal of Clinical Dermatology, 2022, 23 : 61 - 67
  • [4] Facial Redness in Atopic Dermatitis Patients Treated With Dupilumab: A Case Series
    Seok, Seung Hui
    An, Ji Hae
    Shin, Jung U.
    Lee, Hee Jung
    Kim, Dong Hyun
    Yoon, Moon Soo
    Kim, Hyun Jung
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2020, 12 (06) : 1063 - 1065
  • [5] Dupilumab facial redness induced by Rhodotorula mucilaginosa infection
    Esposto, Elia
    Veronese, Federica
    Cammarata, Edoardo
    Savoia, Paola
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2025, 160 (01) : 76 - 77
  • [6] Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective Study
    Beyrouti, Alexandre
    Deuze, Juliette
    Fontas, Eric
    Foureau, Aurore
    Barbarot, Sebastien
    Aubert, Helene
    Bernier, Claire
    Le Moigne, Marie
    Passeron, Thierry
    Boukari, Feriel
    Garnier, Margaux
    Jachiet, Marie
    Tetart, Florence
    Seneschal, Julien
    Toussaiant, Clementine
    Mah, Emmanuel
    Leleu, Camille
    Regnault, Marie Masson
    Pasteur, Justine
    Nosbaum, Audrey
    Badaoui, Antoine
    Fougerousse, Anne-Claire
    Pralong, Pauline
    Viguier, Manuelle
    Droitcourt, Catherine
    Abasq, Claire
    Mallet, Phanie
    Mallet, Stephaine
    Raison-Peyron, Nadia
    Staumont-Sall, Delphine
    Hubiche, Thomas
    Grp Recherche Atopique GREAT Res Grp
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2025, 13 (02): : 353 - 360
  • [7] Use restrictions for Janus kinase inhibitors
    Derrien, Elisa
    ACTUALITES PHARMACEUTIQUES, 2023, 62 (627):
  • [8] Restrictions of use for Janus kinase inhibitors
    Buxeraud, Jacques
    Faure, Sebastien
    ACTUALITES PHARMACEUTIQUES, 2023, 62 (627):
  • [9] Dupilumab facial redness: histologic characterization on a series of four cases
    Dybala, Agnieszka
    Sernicola, Alvise
    Gomes, Vito
    Carnicelli, Giorgia
    Muharremi, Rovena
    Grieco, Teresa
    IMMUNOTHERAPY, 2022, 14 (04) : 183 - 188
  • [10] Dupilumab facial redness: Clinical characteristics and proposed treatment in a cohort
    Fernanda Ordonez-Rubiano, Maria
    Casas, Mirian
    Balaguera-Orjuela, Valentina
    DERMATOLOGIC THERAPY, 2021, 34 (06)
12345